Safe and effective pharmacologic management of arrhythmias.
Razavi
Mehdi
M
The Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas 77030, USA. mehdirazavi@mailsnare.net
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004562:Electrocardiography; D005424:Flecainide / Q000627:therapeutic use; D006801:Humans; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D026941:Sodium Channel Blockers / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D026902:Potassium Channel Blockers; D026941:Sodium Channel Blockers; D005424:Flecainide; D000638:Amiodarone